Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: TL1TR002382
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: UL1TR002378
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: KL2TR002381
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: R25GM058268
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: U54CA118638
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: 1R01GM112490
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: 1R01GM130091
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: 1U01CA225753
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: D-0005
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: W81XWH2110038
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: 20YOUN04
National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
Grant: 2U54MD007602
NCI NIH HHS
Grant: U01 CA225753
NIGMS NIH HHS
Grant: R01 GM112490
NIGMS NIH HHS
Grant: R01 GM130091
Chan Zuckerberg Initiative
Grant: Accelerate Precision Health
National Institutes of Health
Grant: 5UL1TR002378-09
Georgia Clinical & Translational Science Alliance (Georgia CTSA)
National Institutes of Health
Grant: 5U01CA225753-02
Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease
National Institutes of Health
Grant: 5R25GM058268-17
RISE Option III - Morehouse School of Medicine MBRS/RISE
National Institutes of Health
Grant: 5U54MD007602-35
Center for Translational Research in Health Disparities
National Institutes of Health
Grant: 2U54CA118638-02
Cancer Education Program
National Institutes of Health
Grant: 5R01GM130091-07
Quantitative Characterization of Glycopeptide Isomers
National Institutes of Health
Grant: 5R01GM112490-10
Sensitive and Quantitative MS-bases Glycomic Mapping Platform
National Institutes of Health
Grant: 5TL1TR002382-05
J: NRSA Training Core
National Institutes of Health
Grant: 1KL2TR002381-01
Institutional Career Development
Fields of Study
Keywords